2013
DOI: 10.3109/21678421.2013.808225
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina

Abstract: The incidence of amyotrophic lateral sclerosis (ALS) ranges from 1.7 to 2.3 per 100,000 persons worldwide. Few epidemiological studies have been published in Latin America. The aim of this study was to estimate the incidence and prevalence of ALS in an HMO (Health Maintenance Organization) of Buenos Aires, capital city of Argentina. The population studied was affiliates of the Italian Hospital Medical Care Program, whose distribution across age and gender strata is similar to the population of Buenos Aires. Ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 22 publications
0
6
0
Order By: Relevance
“…For the remaining six articles, a graphical reading of the figure of age-specific incidence was performed to obtain rates 4 , 33 , 35 , 52 , 53 , 59 . The demographic structure of the study population was fully available in 25 cases, 6 , 8 , 10–14 , 37 , 38 , 40 , 41 , 43–50 , 55 , 57 , 58 , 61 , 64 , 65 and in four additional studies the number of subjects for the youngest age groups (0-18) was re-calculated based on national census data 3 , 42 , 51 , 66 . For the other studies ( n = 12), the structure of the population under study was retrieved from national demographic databases 4 , 33–36 , 52–54 , 56 , 59 , 62 , 63 …”
Section: Resultsmentioning
confidence: 99%
“…For the remaining six articles, a graphical reading of the figure of age-specific incidence was performed to obtain rates 4 , 33 , 35 , 52 , 53 , 59 . The demographic structure of the study population was fully available in 25 cases, 6 , 8 , 10–14 , 37 , 38 , 40 , 41 , 43–50 , 55 , 57 , 58 , 61 , 64 , 65 and in four additional studies the number of subjects for the youngest age groups (0-18) was re-calculated based on national census data 3 , 42 , 51 , 66 . For the other studies ( n = 12), the structure of the population under study was retrieved from national demographic databases 4 , 33–36 , 52–54 , 56 , 59 , 62 , 63 …”
Section: Resultsmentioning
confidence: 99%
“…Average annual crude incidences reported were 0.26 per 100,000 person-years in Ecuador, 42 to 1.40 per 100,000 person-years in Colombia, 43 and 3.17 per 100,000 person-years in Argentina. 44 There were 3 prevalence studies, 1 each, from Argentina, Colombia, and Brazil. Point prevalence was 4.90 per 100,000 in Colombia, 43 5.00 per 100,000 in Brazil, 45 to 8.86 per 100,000 in Argentina.…”
Section: Resultsmentioning
confidence: 99%
“…Point prevalence was 4.90 per 100,000 in Colombia, 43 5.00 per 100,000 in Brazil, 45 to 8.86 per 100,000 in Argentina. 44 Studies used records from hospitals, clinics, neurologists, and ALS organizations.…”
Section: Europementioning
confidence: 99%
“…Thus, it is difficult to compare our results with the ones from other studies in the same geographic region. A recent study from Argentina, with data collected in the period from January 1, 2003 to December 31, 2010, reported a crude incidence of 3.17/100,000, and the point prevalence of 8.86/100,000 (95% CI 4.05-13.68) [21]; which is the highest reported prevalence of ALS in Latin America. Apart from this Argentinian study, we report a higher ALS prevalence than other studies including Latin America people.…”
Section: Discussionmentioning
confidence: 98%
“…In an American study using capture-recapture method, only considering patients with definite ALS, the estimated prevalence was set 4.7 and 5.0/100,000 in 2012 and 2013 respectively [16], results very similar to ours. Prevalence in Latin America countries ranges from 0.9 to 8.86/100,000 inhabitants [17][18][19][20][21][22][23][24][25][26][27][28][29][30]. However, there are significant methodological differences (e.g., some studies used a different diagnostic category for cases se-lection).…”
Section: Discussionmentioning
confidence: 99%